Wave Life Sciences Reports Third Quarter 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 11/09/20
Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 11/02/20
Wave Life Sciences to Webcast Conference Call of Third Quarter 2020 Financial Results on November 9, 2020GlobeNewsWire • 10/26/20
Wave Life Sciences to Present at the Chardan Virtual 4th Annual Genetic Medicines ConferenceGlobeNewsWire • 09/28/20
Implied Volatility Surging for Wave Life Sciences (WVE) Stock OptionsZacks Investment Research • 09/16/20
Wave Life Sciences to Highlight Preclinical ADAR Editing Data and Neurology Programs at TIDES and OTS Annual MeetingsGlobeNewsWire • 09/15/20
Wave Life Sciences to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceGlobeNewsWire • 09/10/20
Wave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/10/20
Wave Life Sciences Reports Second Quarter 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 08/10/20
Wave Life Sciences to Highlight PRISM Platform Advancements and Preclinical Neurology Pipeline During Analyst and Investor Research WebcastGlobeNewsWire • 08/06/20
Will Wave Life Sciences (WVE) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 08/03/20
Wave Life Sciences to Webcast Conference Call of Second Quarter 2020 Financial Results on August 10, 2020GlobeNewsWire • 07/27/20
Will Wave Life Sciences (WVE) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 07/27/20
Wave Life Sciences Appoints Dr. Ken Rhodes as Senior Vice President, Therapeutics DiscoveryGlobeNewsWire • 05/18/20
Wave Life Sciences Ltd. (WVE) CEO Paul Bolno on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/11/20
Wave Life Sciences Reports First Quarter 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 05/11/20